New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

Persistent hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma and the major indication for liver transplantation in adults. Current standard of care treatment (SOC) with pegylated-interferon-α 2 and ribavirin (RBV) has a limited efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Quer, Josep, Buti, Maria, Cubero, Maria, Guardia, Jaume, Esteban, Rafael, Esteban, Juan Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108733/
https://www.ncbi.nlm.nih.gov/pubmed/21694902
http://dx.doi.org/10.2147/IDR.S7136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108733/
https://www.ncbi.nlm.nih.gov/pubmed/21694902
http://dx.doi.org/10.2147/IDR.S7136

Ejemplares similares